Adjunctive Cilostazol May Aid in the Prevention of Ischemic Vascular Events in Clopidogrel-Treated T2D Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Heart Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel-Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events
J Am Heart Assoc 2020 Dec 17;[EPub Ahead of Print], K Kalantzi, N Tentolouris, AJ Melidonis, S Papadaki, M Peroulis, KA Amantos, G Andreopoulos, GI Bellos, D Boutel, M Bristianou, D Chrisis, NA Dimitsikoglou, J Doupis, C Georgopoulou, SA Gkintikas, S Iraklianou, Κ Kanellas, K Kotsa, T Koufakis, M Kouroglou, AG Koutsovasilis, L Lanaras, E Liouri, C Lixouriotis, A Lykoudi, E Mandalaki, E Papageorgiou, N Papanas, S Rigas, MI Stamatelatou, I Triantafyllidis, A Trikkalinou, AN Tsouka, O Zacharopoulou, C Zoupas, I Tsolakis, AD TselepisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.